Related Experiment Video
Updated: Apr 27, 2026

06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
9.0K
Abnormal cervical cytology after allogeneic bone marrow transplantation
Giovanni Negri1, Martina Herz2, Sara Deola3
1From the Department of Pathology, Central Hospital Bolzano, Bolzano, Italy; ginegri@gmail.com.
American Journal of Clinical Pathology
|July 13, 2014
Summary
Post-allogeneic bone marrow transplant (BMT) Papanicolaou (Pap) smears reveal frequent dysplastic lesions. Busulfan-containing conditioning therapy is linked to therapy-related cytologic atypia, potentially causing unnecessary procedures.
Area of Science:
- Gynecologic Oncology
- Hematology
- Cytopathology
Background:
- Allogeneic bone marrow transplantation (BMT) is a critical treatment for high-risk hematologic malignancies.
- Routine gynecologic follow-up for women post-BMT includes Papanicolaou (Pap) smears.
Purpose of the Study:
- To evaluate Papanicolaou (Pap) smear findings in women following allogeneic bone marrow transplantation (BMT).
- To correlate smear morphology with BMT-related medical treatments, particularly conditioning regimens.
Main Methods:
- Analysis of 117 Pap smears from 54 women who underwent allogeneic BMT.
- Correlation of cytologic findings with specific BMT conditioning therapies and medications.
Main Results:
- Abnormal Pap smears were observed in 24.1% of women post-BMT.
- Atypical squamous cells of unknown significance (ASC-US), low-grade squamous intraepithelial lesions (LSIL), and ASC-H were identified.
- Nine women, including three with ASC-H, received busulfan-based conditioning; no other drug associations were found.
Conclusions:
- Pap smears post-BMT demonstrate a high incidence of dysplastic lesions.
- Busulfan-containing conditioning therapy is frequently associated with therapy-related cytologic atypia.
- Careful evaluation and knowledge of patient history are crucial to avoid unnecessary colposcopies and biopsies.
Related Concept Videos
Bone Marrow Sampling and Transplants
3.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Stem Cell Therapy for Tissue Regeneration
3.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.8K

